; (2) facilities and resources for the diagnosis, prevision, and treatment of fibrotic diseases described in subsection (a); and (3) a long-range plan for the use and organization of national resources to effectively advance research and effectively deal with fibrotic diseases as described in subsection (a), including— (A) comprehensive research plan, which prioritizes fibrosis opportunities that have cross-cutting value and require coordination across multiple national research institutes and centers; (B) topic-specific research recommendations for each organ or system as impacted by fibrotic diseases described in subsection (a); and (C) an overview of common themes and specific steps for implementation. (d) Operating plan Not later than 90 days after its first meeting the Commission shall— (1) submit to the Director of NIH and Congress an operating plan for carrying out the activities of the Commission as described in subsection (c). Such operating plan may include— (A) a list of specific activities that the Commission plans to conduct for purposes of carrying out the duties described in each of paragraphs (1) through (3) of subsection (c); (B) a plan for completing such activities; (C) a list of members of the Commission and other individuals who are not members of the Commission who will need to be involved to conduct such activities; (D) an explanation of involvement and coordination among the institutes and centers of the National Institutes of Health that is needed to conduct such activities; (E) a budget for conducting such activities; and (F) other information that the Commission determines appropriate. (e) Final report Not later than 2 years after the date of the Commission’s first meeting, the Commission shall submit to the Director of NIH and Congress a final report containing all of the findings and recommendations required under subsection (c). (f) Sunset The Commission shall terminate 60 days after submitting its final report, and not later than the end of fiscal year 2022.